Insulin Coverage and Affordability
Supported a large pharmaceutical company with legislative strategy and drafting after analyzing insulin coverage and affordability concerns across payers – including above-brand and brand-specific issues.
Supported a large pharmaceutical company with legislative strategy and drafting after analyzing insulin coverage and affordability concerns across payers – including above-brand and brand-specific issues. Assessed current law implications, identified policy gaps and opportunities for reform. Provided policy recommendations and drafted legislative text to improve insulin coverage and patient affordability, including targeted updates to previously introduced legislation, as well as the creation of new legislation. Provided additional recommendations related to regulatory reforms, as well as stakeholder engagement and alliance building.
CEO insights
Related articles
Real analysis from people who’ve been there
Evaluation of Biosimilar Utilization by Hospital Types
Worked with a pharmaceutical trade organization to identify biosimilars of interest.
Advocacy Coalition for Uptake of Comprehensive Genomic Profiling
Worked with a diverse group of industry stakeholders including diagnostics manufacturers, laboratories, academic institutions, and disease-specific advocacy groups to redefine comprehensive genomic profiling through the creation of a “new narrative”.
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.